Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
948.8 INR | +0.79% | +0.36% | +46.15% |
05-23 | Strides Pharma Science Turns to Consolidated Net Profit in Fiscal Q4; Shares Down 3% | MT |
05-22 | Transcript : Strides Pharma Science Limited, Q4 2024 Earnings Call, May 22, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+46.15% | 1.05B | |
+20.76% | 43.77B | |
+28.00% | 22.83B | |
+20.25% | 15.56B | |
+18.82% | 14.34B | |
+55.83% | 12.96B | |
-0.05% | 6.79B | |
-12.70% | 6.41B | |
-8.87% | 5.73B | |
+14.65% | 5.69B |
- Stock Market
- Equities
- STAR Stock
- News Strides Pharma Science Limited
- Strides Pharma Science Arm Gets US FDA Nod for Sevelamer Carbonate for Oral Suspension